Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Sarepta Therapeutics, Inc. | Director | Common Stock | 12.4K | $993K | $80.34 | Mar 7, 2022 | Direct |
RAPT Therapeutics, Inc. | Director | Stock Option (right to buy) | 36.5K | $277K | $7.58 | May 22, 2024 | Direct |
BioAtla, Inc. | Director | Common Stock | 53.9K | $81.4K | $1.51 | Jun 13, 2024 | Direct |
PALISADE BIO, INC. | Director | Restricted Stock Units | 5.82K | $2.97K | $0.51 | Nov 21, 2023 | Direct |
Compass Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 40K | Feb 9, 2024 | Direct | ||
Keros Therapeutics, Inc. | Director | Stock Option (right to buy) | 10K | May 30, 2024 | Direct | ||
PALISADE BIO, INC. | Director | Common Stock Options | 6.88K | Nov 21, 2023 | Direct | ||
Sarepta Therapeutics, Inc. | Director | Stock Option (right to buy) | 5.08K | Mar 7, 2022 | Direct |